| Q33772964 | A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1. |
| Q35221427 | A genetic association study of activated partial thromboplastin time in European Americans and African Americans: the ARIC Study |
| Q37708719 | A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium |
| Q28478614 | A genome-wide association study of the Protein C anticoagulant pathway |
| Q36166323 | A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. |
| Q31113588 | A genome-wide search for common SNP x SNP interactions on the risk of venous thrombosis |
| Q40142760 | A model-based 'varimax' sampling strategy for a heterogeneous population |
| Q34540173 | A variant in the ABO gene explains the variation in soluble E-selectin levels-results from dense genotyping in two independent populations |
| Q36361023 | ABO Blood Groups and Cardiovascular Diseases |
| Q62516283 | ABO blood group A transferases catalyze the biosynthesis of FORS blood group FORS1 antigen upon deletion of exon 3 or 4 |
| Q61974432 | ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis? |
| Q64966406 | ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity. |
| Q38031586 | ABO blood group, hypercoagulability, and cardiovascular and cancer risk |
| Q37859751 | ABO blood groups and thrombosis: a causal association, but is there value in screening? |
| Q37678030 | ABO blood type A is associated with increased risk of ARDS in whites following both major trauma and severe sepsis |
| Q37019834 | ABO blood type and stroke risk: the REasons for Geographic And Racial Differences in Stroke Study. |
| Q36358536 | ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer |
| Q48371897 | Advances in predicting venous thromboembolism risk in children. |
| Q38172629 | Advances in understanding stroke risk in children--a geneticist's view |
| Q36359074 | Association of ABO and Colton Blood Group Gene Polymorphisms With Hematological Traits Variation. |
| Q89863386 | Association of ABO polymorphisms and pancreatic Cancer/ Cardiocerebrovascular disease: a meta-analysis |
| Q90401815 | Association of SERPINC1 Gene Polymorphism (rs2227589) With Pulmonary Embolism Risk in a Chinese Population |
| Q57053779 | Association of the CYP4V2 polymorphism rs13146272 with venous thromboembolism in a Chinese population |
| Q102058933 | Associations between blood type and COVID-19 infection, intubation, and death |
| Q39206682 | Associations between polymorphisms in coagulation-related genes and venous thromboembolism: A meta-analysis with trial sequential analysis |
| Q50077941 | Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis. |
| Q53786410 | Better or worse than the original. |
| Q33610639 | Blood type, ABO genetic variants, and ovarian cancer survival |
| Q33931897 | C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies |
| Q28728919 | Caution in interpreting results from imputation analysis when linkage disequilibrium extends over a large distance: a case study on venous thrombosis |
| Q24318690 | Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels |
| Q36105702 | Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD. |
| Q38117729 | Current knowledge on the genetics of incident venous thrombosis. |
| Q34410116 | DNA methylation and body-mass index: a genome-wide analysis |
| Q91652826 | Dataset of GWAS-identified variants underlying venous thromboembolism susceptibility and linkage to cancer aggressiveness |
| Q37155183 | Deficiencies of the Natural Anticoagulants - Novel Clinical Laboratory Aspects of Thrombophilia Testing |
| Q31115221 | Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+). |
| Q36259417 | Dissecting the genetic determinants of hemostasis and thrombosis |
| Q45323948 | Distribution of ABO/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: a population-based cross-sectional study. |
| Q38162754 | Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians |
| Q33729508 | EPCR Gene Ser219Gly Polymorphism and Venous Thromboembolism: A Meta-Analysis of 9,494 Subjects |
| Q35225415 | Economic analysis of thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism |
| Q38986410 | Environmental and Genetic Risk Factors Associated with Venous Thromboembolism |
| Q41667853 | Epidemiology of venous thromboembolism |
| Q38205103 | Extraintestinal manifestations and complications in inflammatory bowel disease: from shared genetics to shared biological pathways |
| Q58955398 | Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients-results from the Vienna Cancer And Thrombosis Study (CATS) |
| Q30300355 | Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans |
| Q36096131 | Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease |
| Q30235420 | Genetic factors in pediatric venous thromboembolism |
| Q34905471 | Genetic polymorphism of NOS3 with susceptibility to deep vein thrombosis after orthopedic surgery: a case-control study in Chinese Han population |
| Q33988457 | Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development |
| Q36096028 | Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies |
| Q47737319 | Genetic variation influences the risk of bleeding after cardiac surgery: novel associations and validation of previous findings |
| Q35032797 | Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism |
| Q37738343 | Genetics of atherothrombosis and thrombophilia |
| Q28744518 | Genetics of venous thrombosis: insights from a new genome wide association study |
| Q57611749 | Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project |
| Q30277281 | Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis |
| Q91063038 | Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease |
| Q35008233 | Genome-wide association study on serum alkaline phosphatase levels in a Chinese population. |
| Q45903844 | Genome-wide linkage scan in affected sibling pairs identifies novel susceptibility region for venous thromboembolism: Genetics In Familial Thrombosis study. |
| Q34674600 | Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists |
| Q38014677 | Genomics and epigenomics of the human glycome. |
| Q28247002 | Human metabolic individuality in biomedical and pharmaceutical research |
| Q29417010 | Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies |
| Q34165506 | Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes |
| Q92395349 | Identifying mutation-driven changes in gene functionality that lead to venous thromboembolism |
| Q53794226 | Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels. |
| Q36277129 | Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort |
| Q38178063 | Inherited risk factors for venous thromboembolism |
| Q88009010 | Interaction of a genetic risk score with physical activity, physical inactivity, and body mass index in relation to venous thromboembolism risk |
| Q53080453 | Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism. |
| Q34251897 | Is ABO blood group truly a risk factor for thrombosis and adverse outcomes? |
| Q40689903 | Is there still room for additional common susceptibility alleles for venous thromboembolism? |
| Q36637803 | Ischemic stroke is associated with the ABO locus: the EuroCLOT study |
| Q57605671 | Lack of association of non-synonymous FUT2 and ALPL polymorphisms with venous thrombosis |
| Q51009301 | Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits. |
| Q37903948 | Lessons from genome-wide association studies in venous thrombosis. |
| Q35266365 | Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism |
| Q34969475 | Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study |
| Q28661433 | Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease |
| Q35070627 | Multilocus genetic risk scores for venous thromboembolism risk assessment |
| Q35939912 | New gene variants associated with venous thrombosis: a replication study in White and Black Americans |
| Q44889703 | Next-generation sequencing study finds an excess of rare, coding single-nucleotide variants of ADAMTS13 in patients with deep vein thrombosis. |
| Q36800467 | Novel genetic predictors of venous thromboembolism risk in African Americans. |
| Q35193732 | Novel loci involved in platelet function and platelet count identified by a genome-wide study performed in children. |
| Q51537947 | Parental history and venous thromboembolism: a nationwide study of age-specific and sex-specific familial risks in Sweden. |
| Q36965849 | Personalized medicine in thrombosis: back to the future |
| Q57303396 | Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors |
| Q41458663 | Prevalence of Hereditary Thrombophilia in Patients Older Than 75 Years With Venous Thromboembolism Referred for Thrombophilia Screening |
| Q40049106 | Prevalence of common hereditary risk factors for thrombophilia in Somalia and identification of a novel Gln544Arg mutation in coagulation factor V. |
| Q89718029 | Progress in the research on venous thromboembolism |
| Q85118673 | Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies |
| Q36199721 | Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). |
| Q36079864 | Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study |
| Q36625170 | Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). |
| Q36594002 | Race, ABO blood group, and venous thromboembolism risk: not black and white. |
| Q50500598 | Relationship between ABO genotype and A antigen expression on platelets. |
| Q98905652 | Retrospective Analysis of Clinical Features in 134 Coronavirus Disease 2019 Cases |
| Q36698661 | Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type |
| Q27008212 | Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants |
| Q34745315 | Sickle cell trait: is there an increased VTE risk in pregnancy and the postpartum? |
| Q35959692 | Single Nucleotide Variant rs2232710 in the Protein Z-Dependent Protease Inhibitor (ZPI, SERPINA10) Gene Is Not Associated with Deep Vein Thrombosis |
| Q38633142 | Sticky platelet syndrome: an important cause of life-threatening thrombotic complications. |
| Q38818503 | Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis. |
| Q33973390 | Targeted gene sequencing identifies variants in the protein C and endothelial protein C receptor genes in patients with unprovoked venous thromboembolism |
| Q40288573 | The ENTPD1 promoter polymorphism -860 A > G (rs3814159) is associated with increased gene transcription, protein expression, CD39/NTPDase1 enzymatic activity, and thromboembolism risk. |
| Q35849271 | The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies. |
| Q35149898 | The genetics of common variation affecting platelet development, function and pharmaceutical targeting |
| Q50199930 | The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants |
| Q47983961 | Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study. |
| Q37479952 | Thrombosis Related ABO, F5, MTHFR, and FGG Gene Polymorphisms in Morbidly Obese Patients. |
| Q34422433 | Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium |
| Q39374276 | Venous thromboembolism does not share strong familial susceptibility with pre-eclampsia/eclampsia: a nationwide family study in Sweden |
| Q57611689 | What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies |
| Q47120217 | Whole exome sequencing in thrombophilic pedigrees to identify genetic risk factors for venous thromboembolism. |
| Q89777077 | Whole-exome sequencing in evaluation of patients with venous thromboembolism |
| Q89287144 | microRNAs regulate nitric oxide release from endothelial cells by targeting NOS3 |